Extraordinary meeting of the Committee for Medicinal Products for Human Use (CHMP): 25 October 2021

• Date:
  Monday, 25 October 2021, All day
• Location:
  Online
  European Medicines Agency, Amsterdam, the Netherlands

This extraordinary plenary meeting is organised in the context of the evaluation of an application for the use of a booster dose for the COVID-19 vaccine Spikevax.

The aim of the meeting is to conclude this evaluation, if possible.

The Committee for Medicinal Products for Human Use (CHMP) is responsible for preparing the Agency's opinions on all questions concerning human medicines.